bromocriptine has been researched along with sk&f-38393 in 106 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 31 (29.25) | 18.7374 |
1990's | 56 (52.83) | 18.2507 |
2000's | 16 (15.09) | 29.6817 |
2010's | 3 (2.83) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
George, SR; Guan, HC; Laurier, LG; Ng, G; Niznik, HB; O'Dowd, BF; Seeman, P; Sunahara, RK; Torchia, J; Van Tol, HH | 1 |
Brusniak, MY; DuRand, CJ; Huang, WH; Neve, KA; Pearlman, RS; Teeter, MM; Wiens, BL; Wilcox, DM; Wilcox, RE | 1 |
Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
Choi, AL; Gallo, F; Martínez de la Escalera, G; Weiner, RI | 1 |
Cao, Y; Eberwine, J; Kitai, ST; Stefani, A; Surmeier, DJ; Wilson, CJ | 1 |
Chang, JP; Peter, RE; Wong, AO | 1 |
Kruk, ZL; Millar, J; Stamford, JA | 1 |
Horn, PT; Kohli, JD | 1 |
Bruhwyler, J; Chleide, E; Delarge, J; Liégeois, JF; Mercier, M | 1 |
Forgione, A; Missale, C; Rizzonelli, P; Sigala, S; Spano, P; Zanelli, E | 1 |
Nikulina, EM; Popova, NK; Skrinskaya, JA | 1 |
Hosseini-Nia, T; Owji, AA; Zarrindast, MR | 1 |
Minaian, A; Zarrindast, MR | 1 |
Eliassi, A; Zarrindast, MR | 1 |
Häberle, DA; Königbauer, B | 1 |
Cestari, R; Lojacono, L; Memo, M; Missale, C; Missale, G; Sigala, S; Spano, P | 1 |
Adams, EF; Fahlbusch, R; Nomikos, P; Reif, M; Schrell, UM | 1 |
Barden, N; L'Héreault, S | 1 |
Hara, M; Sasa, M; Takaori, S | 1 |
Armstrong, WE; Crowley, WR; Grosvenor, CE; Parker, SL; Wang, W | 1 |
Bédard, PJ; Di Paolo, T; Gagnon, C | 1 |
Amenta, F; Cavallotti, C; Collier, WL; De Michele, M; Ricci, A | 1 |
Inoue, T; Kontani, H; Sakai, T | 1 |
Fernández, M; Jantos, H; Monti, JM | 1 |
Denis, P; Elena, PP; Lapalus, P; Nordmann, JP; Saraux, H | 1 |
Bédard, PJ; Di Paolo, T; Rouillard, C | 1 |
Shahed-Dirin, K; Zarrindast, MR | 1 |
Beaulieu, M; Felder, R; Kebabian, JW | 1 |
Dieguez, C; Hall, R; Lewis, BM; Lewis, M; Scanlon, MF | 1 |
Poursoltan, M; Zarrindast, MR | 1 |
Kostowski, W; Krzaścik, P; Puciłowski, O; Staniszewska, A; Trzaskowska, E | 1 |
Edwards, SR; Jackson, DM; Ross, SB | 1 |
Beart, PM; Cook, CJ; Hashizume, M; Jackson, DM; Tabar, J | 1 |
Hashizume, M; Jackson, DM; Ross, SB | 2 |
Chagraoui, A; Protais, P; Vasse, M | 1 |
Mizuki, Y; Ushijima, I; Yamada, M | 2 |
Hara, T; Kaneyuki, H; Kishimoto, O; Mizuki, Y; Soeda, K; Tsutsumi, C; Ushijima, I; Yamada, M | 1 |
Robertson, GS; Robertson, HA | 1 |
Hashizume, M; Jackson, DM | 2 |
Greer, NL; Schechter, MD | 1 |
Walters, JR; Weick, BG | 1 |
Millington, WR; Mueller, GP; O'Donohue, TL | 1 |
Bédard, P; Di Paolo, T; Falardeau, P; Rouillard, C | 1 |
Feuerstein, TJ; Hertting, G; Jackisch, R; Moll, S | 1 |
Burchill, SA; Thody, AJ | 1 |
Block, H; Klemm, WR | 1 |
Carruba, MO; Liberini, P; Memo, M; Missale, C; Spano, P | 1 |
Biziere, K; Gueudet, C; Worms, P | 1 |
Ohno, Y; Sasa, M; Takaori, S | 1 |
Briley, M; Langer, SZ; Lehmann, J | 1 |
Bendesky, RJ; Martin, GE | 1 |
Ginos, JZ; Goldberg, LI; Woolverton, WL | 1 |
Lang, WJ; Rechtman, MP; Woodman, OL | 1 |
McDevitt, JT; Setler, PE | 1 |
Lang, WJ; Woodman, OL | 1 |
Bengtsson, A; Georgiev, J; Jackson, DM; Larsson, LG; Magnusson, O; Mohell, N; Ross, SB | 1 |
Gueudet, C; Gully, D; Le Fur, G; Poncelet, M; Soubrié, P; Souilhac, J; Terranova, JP | 1 |
Shibata, S; Tanaka, T; Watanabe, S; Yamamoto, Y | 1 |
George, SR; Ng, GY | 1 |
Silverman, PB | 1 |
Kitai, ST; Surmeier, DJ | 1 |
Cestari, R; Lojacono, L; Missale, C; Missale, G; Raddino, R; Sigala, S; Spano, PF | 1 |
Gomez, A; Gonzalez, M; Motles, E; Tetas, M | 1 |
Archer, T; Fredriksson, A; Plaznik, A; Sundström, E | 1 |
Atrens, DM; Hunt, GE; Jackson, DM | 1 |
Kamijo, N; Nagao, T; Ono, H | 1 |
Dollison, A; Espinosa, A; Ferreira, M; Jackson-Lewis, V; Jiang, H; Muthane, U; Parsons, B; Przedborski, S | 1 |
Giraud, P; Kowalski, C | 1 |
Dahmer, MK; Senogles, SE | 2 |
Akiyama, K; Ishihara, T; Kashihara, K; Shiro, Y; Shohmori, T | 1 |
Carriero, DL; Cousins, MS; Salamone, JD | 1 |
Fici, GJ; Sethy, VH; VonVoigtlander, PF; Wu, H | 1 |
Cho, S; Hadjiconstantinou, M; Neff, NH | 1 |
Braghiroli, L; De Feo, G; Giacomelli, S; Koppenaal, DW; Ponzianelli, A | 1 |
Cincotta, AH; Scislowski, PW; Tozzo, E | 1 |
Azaryan, AV; Clock, BJ; Cox, BM; Rosenberger, JG | 1 |
Cheng, CY; Giacomelli, S; Palmery, M; Romanelli, L; Silvestrini, B | 1 |
Allain, H; Bentué-Ferrer, D; Cardwell, GP; Hicks, CA; O'Neill, MJ; Reymann, JM; Ward, MA | 1 |
Cincotta, AH; Liang, Y; Lubkin, M; Scislowski, PW; Sheng, H | 1 |
Bormann, J; Brünig, I; Hatt, H; Sommer, M | 1 |
Coronas, V; Jourdan, F; Krantic, S; Moyse, E | 1 |
Gáborján, A; Lendvai, B; Vizi, ES | 1 |
Cincotta, AH; Phaneuf, S; Prevelige, R; Scislowski, PW; Tozzo, E; Zhang, Y | 1 |
Cincotta, AH; Phaneuf, S; Prevelige, R; Scislowski, PW; Zhang, Y | 1 |
Abe, K; Akiyama, K; Ishihara, T; Kashihara, K | 1 |
Cincotta, AH; Kraszewski, KZ | 1 |
Gu, Q; Kwong, E | 1 |
Arilla-Ferreiro, E; del Boyano-Adánez, M; Izquierdo-Claros, RM | 1 |
Breton, B; Mañanos, EL; Marmignon, MH; Saligaut, C; Vacher, C | 1 |
Canales, JJ; Iversen, SD | 1 |
Collazo, R; Di Sole, F; Fan, L; Helmle-Kolb, C; Moe, OW; Murer, H; Quiñones, H; Wiederkehr, MR | 1 |
Salvi, RJ; Sun, W | 1 |
Cincotta, AH; Liang, Y | 1 |
Hillman, R; Parvez, F; Pendleton, RG; Sayed, M | 1 |
Blakemore, LJ; Davila, NG; Trombley, PQ | 1 |
Kayir, H; Uzbay, IT | 1 |
Fujinami, A; Kuno, S; Matsui, H; Mizuta, I; Ohta, K; Ohta, M | 1 |
Cox, CL; Govindaiah, G | 1 |
Cenci, MA; Lindgren, HS; Ohlin, KE | 1 |
Fujinami, A; Ikeda, E; Inoue, S; Kuno, S; Ohta, K; Ohta, M | 1 |
Geyer, MA; Meves, JM; Sharp, RF; Tarantino, IS; Young, JW | 1 |
Cheng, RK; Chiang, FK; Liao, RM | 1 |
1 review(s) available for bromocriptine and sk&f-38393
Article | Year |
---|---|
D1 and D2 dopamine receptor modulation of sodium and potassium currents in rat neostriatal neurons.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Bromocriptine; Dopamine Agents; Embryo, Mammalian; Ergolines; In Vitro Techniques; Neostriatum; Neurons; Potassium Channels; Quinpirole; Rats; Receptors, Dopamine D1; Receptors, Dopamine D2; RNA, Messenger; Sodium Channels | 1993 |
105 other study(ies) available for bromocriptine and sk&f-38393
Article | Year |
---|---|
Cloning of the gene for a human dopamine D5 receptor with higher affinity for dopamine than D1.
Topics: Amino Acid Sequence; Animals; Base Sequence; Binding, Competitive; Blotting, Northern; Brain; Cell Line; Cell Membrane; Cloning, Molecular; Dopamine; Humans; Kinetics; Molecular Sequence Data; Molecular Weight; Oligonucleotide Probes; Rats; Receptors, Dopamine; Receptors, Dopamine D1; Receptors, Dopamine D5; RNA, Messenger; Sequence Homology, Nucleic Acid; Transfection | 1991 |
CoMFA-based prediction of agonist affinities at recombinant wild type versus serine to alanine point mutated D2 dopamine receptors.
Topics: Alanine; Amino Acid Substitution; Animals; Bromocriptine; Combinatorial Chemistry Techniques; Dopamine Agonists; Models, Molecular; Pergolide; Point Mutation; Radioligand Assay; Rats; Receptors, Dopamine D2; Recombinant Proteins; Serine; Structure-Activity Relationship; Tumor Cells, Cultured | 2000 |
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Dopaminergic regulation of the GT1 gonadotropin-releasing hormone (GnRH) neuronal cell lines: stimulation of GnRH release via D1-receptors positively coupled to adenylate cyclase.
Topics: 1-Methyl-3-isobutylxanthine; 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Adenylyl Cyclases; Benzazepines; Bromocriptine; Cell Line; Cyclic AMP; Dopamine; Dopamine and cAMP-Regulated Phosphoprotein 32; Gonadotropin-Releasing Hormone; Kinetics; Nerve Tissue Proteins; Neurons; Norepinephrine; Phosphoproteins; Receptors, Dopamine D1; RNA, Messenger; Spiperone | 1992 |
Dopamine receptor subtypes colocalize in rat striatonigral neurons.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Antisense Elements (Genetics); Base Sequence; Blotting, Southern; Bromocriptine; DNA; Ergolines; Evoked Potentials; Microscopy, Fluorescence; Molecular Sequence Data; Neostriatum; Neurons; Oligodeoxyribonucleotides; Quinpirole; Rats; Receptors, Dopamine; Receptors, Dopamine D1; Receptors, Dopamine D2; Receptors, Dopamine D3; RNA Probes; RNA, Messenger; Sodium Channels; Substantia Nigra | 1992 |
Dopamine stimulates growth hormone release from the pituitary of goldfish, Carassius auratus, through the dopamine D1 receptors.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Benzazepines; Bromocriptine; Domperidone; Dopamine; Dopamine Agents; Dose-Response Relationship, Drug; Ergolines; Goldfish; Gonadotropin-Releasing Hormone; Growth Hormone; Pituitary Gland; Quinpirole; Radioimmunoassay; Receptors, Dopamine | 1992 |
Differential effects of dopamine agonists upon stimulated limbic and striatal dopamine release: in vivo voltammetric data.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Apomorphine; Bromocriptine; Corpus Striatum; Dopamine; Dopamine Agents; Electrochemistry; Electrophysiology; Ergolines; In Vitro Techniques; Limbic System; Male; Microelectrodes; Nucleus Accumbens; Pergolide; Piperidines; Quinpirole; Rats; Rats, Inbred Strains; Stereotaxic Techniques | 1991 |
Absence of postsynaptic DA2 dopamine receptors in the dog renal vasculature.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Bromocriptine; Dogs; Dopamine; Dopamine Agents; Ergolines; Fenoldopam; Histamine Antagonists; Male; Quinpirole; Receptors, Dopamine; Renal Circulation; Sympatholytics; Synapses; Vasodilation | 1991 |
Effects of specific dopaminergic agonists and antagonists in the open-field test.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Behavior, Animal; Benzazepines; Bromocriptine; Defecation; Dopamine Agents; Dopamine Antagonists; Imidazoles; Motor Activity; Parasympatholytics; Rats; Rats, Inbred Strains | 1991 |
Low doses of l-sulpiride down-regulate striatal and cortical dopamine receptors and beta-adrenoceptors.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Adenylyl Cyclases; Animals; Binding Sites; Bromocriptine; Corpus Striatum; Dopamine; Down-Regulation; Fenoldopam; Frontal Lobe; Male; Norepinephrine; Radioimmunoassay; Rats; Rats, Inbred Strains; Receptors, Adrenergic, beta; Receptors, Dopamine; Sulpiride | 1991 |
Role of genotype and dopamine receptors in behaviour of inbred mice in a forced swimming test.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Analysis of Variance; Animals; Behavior, Animal; Benzazepines; Bromocriptine; Depression; Dopamine Agents; Ergolines; Genotype; Mice; Mice, Inbred Strains; Quinpirole; Receptors, Dopamine; Sulpiride; Swimming | 1991 |
Evaluation of dopamine receptor involvement in rat feeding behaviour.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Appetite Depressants; Bromocriptine; Dopamine Agents; Dose-Response Relationship, Drug; Ergolines; Feeding Behavior; Male; Quinpirole; Rats; Receptors, Dopamine; Receptors, Dopamine D1; Receptors, Dopamine D2; Reserpine; Serotonin Antagonists | 1991 |
Different effects of direct and indirect dopamine receptor agonists on immobility time in reserpine-treated mice.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Apomorphine; Benzazepines; Bromocriptine; Bupropion; Dopamine Agents; Dopamine Antagonists; Ergolines; Injections, Subcutaneous; Male; Mice; Motor Activity; Quinpirole; Receptors, Dopamine; Receptors, Dopamine D1; Receptors, Dopamine D2; Reserpine; Sulpiride; Swimming | 1991 |
Differential effects of dopamine agonists on locomotion in intact and reserpine-treated mice.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; alpha-Methyltyrosine; Animals; Apomorphine; Benzazepines; Bromocriptine; Dopamine Agents; Dose-Response Relationship, Drug; Ergolines; Male; Methyltyrosines; Mice; Motor Activity; Quinpirole; Receptors, Dopamine; Receptors, Dopamine D1; Receptors, Dopamine D2; Reserpine; Sulpiride; Tyrosine 3-Monooxygenase | 1991 |
Inhibition of tubuloglomerular feedback by the D1 agonist fenoldopam in chronically salt-loaded rats.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Benzazepines; Bromocriptine; Dopamine Agents; Dose-Response Relationship, Drug; Feedback; Fenoldopam; Glomerular Filtration Rate; Kidney Glomerulus; Kidney Tubules; Male; Metoclopramide; Rats; Rats, Inbred Strains; Sodium, Dietary | 1991 |
Evidence for the presence of both D-1 and D-2 dopamine receptors in human esophagus.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Adenylyl Cyclases; Adult; Benzazepines; Bromocriptine; Butaclamol; Dopamine Agents; Dose-Response Relationship, Drug; Esophagus; Fenoldopam; Humans; Male; Middle Aged; Receptors, Dopamine; Receptors, Dopamine D1; Receptors, Dopamine D2; Sulpiride | 1990 |
Growth of cultured human cerebral meningiomas is inhibited by dopaminergic agents. Presence of high affinity dopamine-D1 receptors.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Apomorphine; Benzazepines; Binding, Competitive; Bromocriptine; Butaclamol; Cell Division; Dopamine; Dopamine Agents; Humans; Meningioma; Receptors, Dopamine; Receptors, Dopamine D1; Tumor Cells, Cultured | 1990 |
Monoaminergic regulation of proopiomelanocortin messenger RNA concentrations in primary cell cultures of rat hypothalamus.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Acetylcholine; Animals; Bromocriptine; Butaclamol; Cells, Cultured; Dexamethasone; Dopamine; Embryo, Mammalian; Haloperidol; Hypothalamus; Kinetics; Norepinephrine; Nucleic Acid Hybridization; Pro-Opiomelanocortin; Rats; Rats, Inbred Strains; RNA Probes; RNA, Messenger | 1991 |
Dopamine D-1 receptor-mediated inhibition of nucleus accumbens neurons from the ventral tegmental area.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Benzazepines; Bromocriptine; Domperidone; Dopamine Antagonists; Electric Stimulation; Electrodes; Haloperidol; Iontophoresis; Male; Neurons; Nucleus Accumbens; Rats; Rats, Inbred Strains; Receptors, Dopamine; Receptors, Dopamine D1; Thalamic Nuclei | 1991 |
Excitatory and inhibitory dopaminergic regulation of oxytocin secretion in the lactating rat: evidence for respective mediation by D-1 and D-2 dopamine receptor subtypes.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Benzazepines; Bromocriptine; Domperidone; Dopamine; Dopamine Antagonists; Electric Stimulation; Female; Lactation; Naltrexone; Oxytocin; Pituitary Gland; Rats; Receptors, Dopamine; Receptors, Dopamine D1; Receptors, Dopamine D2; Vasopressins | 1991 |
Effect of chronic treatment of MPTP monkeys with dopamine D-1 and/or D-2 receptor agonists.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Autoradiography; Brain; Bromocriptine; Carbidopa; Catecholamines; Dopamine Agents; Female; Levodopa; Macaca fascicularis; Receptors, Dopamine; Spiperone | 1990 |
Age-related changes of dopamine sensitive cyclic AMP generation in the rat frontal cortex.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Aging; Animals; Apomorphine; Benzazepines; Bromocriptine; Cyclic AMP; Dopamine; Dopamine Agents; Dopamine Antagonists; Ergolines; Fenoldopam; Frontal Lobe; Male; Quinpirole; Rats; Rats, Inbred Strains | 1990 |
Dopamine receptor subtypes that induce hyperactive urinary bladder response in anesthetized rats.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Anesthesia; Animals; Bromocriptine; Drug Synergism; Male; Muscle Contraction; Rats; Rats, Inbred Strains; Receptors, Dopamine; Urinary Bladder | 1990 |
Sleep during acute dopamine D1 agonist SKF 38393 or D1 antagonist SCH 23390 administration in rats.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Amphetamines; Animals; Benzazepines; Bromocriptine; Dopamine Antagonists; Dose-Response Relationship, Drug; Male; Rats; Rats, Inbred Strains; Receptors, Dopamine; Receptors, Dopamine D1; Reference Values; Serotonin Antagonists; Sleep; Sleep, REM; Wakefulness | 1990 |
Autoradiographic localization of D1 and D2 dopamine binding sites in the human retina.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Aged; Aged, 80 and over; Autoradiography; Benzazepines; Bromocriptine; Domperidone; Dopamine Antagonists; Humans; Iodine Radioisotopes; Middle Aged; Receptors, Dopamine; Receptors, Dopamine D1; Receptors, Dopamine D2; Retina; Sulpiride | 1990 |
Effects of chronic treatment of MPTP monkeys with bromocriptine alone or in combination with SKF 38393.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; 3,4-Dihydroxyphenylacetic Acid; Animals; Antiparkinson Agents; Brain; Brain Chemistry; Bromocriptine; Dopamine; Female; Homovanillic Acid; Kinetics; Levodopa; Macaca fascicularis; Motor Activity; MPTP Poisoning; Parkinson Disease, Secondary; Receptors, Dopamine; Spiperone | 1990 |
Bromocriptine induces climbing behaviour: possible D-1 or D-2 dopamine receptor involvement.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; alpha-Methyltyrosine; Animals; Apomorphine; Behavior, Animal; Bromocriptine; Dopamine Antagonists; Dose-Response Relationship, Drug; Drug Synergism; Male; Methyltyrosines; Mice; Pimozide; Receptors, Dopamine; Reserpine; Sulpiride | 1990 |
D-2 dopaminergic agonists and adenosine 3',5'-monophosphate directly regulate the synthesis of alpha-melanocyte-stimulating hormone-like peptides by cultured rat melanotrophs.
Topics: 1-Methyl-3-isobutylxanthine; 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; 8-Bromo Cyclic Adenosine Monophosphate; Animals; Benzamides; Benzazepines; Bromocriptine; Cells, Cultured; Chemical Precipitation; Cholera Toxin; Chromatography, High Pressure Liquid; Colforsin; Cyclic AMP; Dopamine; Ergolines; Immunologic Techniques; Melanocyte-Stimulating Hormones; Pituitary Gland; Pro-Opiomelanocortin; Quinpirole; Rats; Receptors, Dopamine; Spiperone | 1986 |
Hypothalamic D2 receptors mediate the preferential release of somatostatin-28 in response to dopaminergic stimulation.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Benzazepines; Bromocriptine; Butaclamol; Domperidone; Dopamine; Ergolines; Hypothalamus; Male; Metoclopramide; Quinpirole; Rats; Rats, Inbred Strains; Receptors, Dopamine; Receptors, Dopamine D2; Somatostatin; Somatostatin-28 | 1986 |
Interactions of drugs acting on central dopamine receptors and cholinoceptors on yawning responses in the rat induced by apomorphine, bromocriptine or physostigmine.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Apomorphine; Atropine; Behavior, Animal; Benzazepines; Bromocriptine; Drug Interactions; Male; Physostigmine; Rats; Receptors, Cholinergic; Receptors, Dopamine; Theophylline; Yawning | 1989 |
On the relative importance of D-1 vs. D-2 dopaminergic receptors in the control of audiogenic seizures in ethanol withdrawn rats.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Acoustic Stimulation; Animals; Benzazepines; Bromocriptine; Ethanol; Male; Rats; Rats, Inbred Strains; Receptors, Dopamine; Seizures; Substance Withdrawal Syndrome | 1989 |
Dopamine D2 agonist-induced behavioural depression is reversed by dopamine D1 agonists.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Benzazepines; Bromocriptine; Dose-Response Relationship, Drug; Ergolines; Indoles; Male; Mice; Motor Activity; Phenanthridines; Quinpirole; Receptors, Dopamine | 1989 |
The effects on central dopamine function of chronic L-dopa (methyl ester hydrochloride) treatment of mice.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Apomorphine; Behavior, Animal; Benzazepines; Body Temperature; Bromocriptine; Dextroamphetamine; Dopamine; Levodopa; Mice; Mice, Inbred Strains; Motor Activity; Receptors, Dopamine; Stereotyped Behavior | 1989 |
Further studies on the interaction between bromocriptine and SKF38393 in reserpine and alpha methyl-para-tyrosine-treated mice.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; alpha-Methyltyrosine; Animals; Apomorphine; Appetite Depressants; Benzazepines; Bromocriptine; Drug Interactions; In Vitro Techniques; Male; Methyltyrosines; Mice; Motor Activity; Reserpine; Tyrosine 3-Monooxygenase | 1988 |
Climbing and stereotyped behaviours in mice require the stimulation of D-1 dopamine receptors.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Antipsychotic Agents; Apomorphine; Appetite Depressants; Behavior, Animal; Benzazepines; Bromocriptine; Ergolines; Male; Mice; Mice, Inbred Strains; Piribedil; Quinpirole; Receptors, Dopamine; Stereotyped Behavior | 1988 |
The mode of action of bromocriptine following pretreatment with reserpine and alpha-methyl-p-tyrosine in rats.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; alpha-Methyltyrosine; Animals; Benzazepines; Bromocriptine; Male; Methyltyrosines; Rats; Rats, Inbred Strains; Receptors, Dopamine; Receptors, Dopamine D1; Receptors, Dopamine D2; Reserpine; Tyrosine 3-Monooxygenase; Yawning | 1988 |
Dopamine-mediated behaviours produced in naive mice by bromocriptine plus SKF 38393.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Appetite Depressants; Behavior, Animal; Benzazepines; Bromocriptine; Dopamine; Grooming; Male; Mice; Mice, Inbred Strains; Motor Activity | 1988 |
[Effects of bifemelane on central dopaminergic and cholinergic systems in rats].
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Antidepressive Agents; Apomorphine; Benzazepines; Benzhydryl Compounds; Bromocriptine; Dopamine Agents; Drug Interactions; Male; Physostigmine; Pilocarpine; Rats; Rats, Inbred Strains; Stereotyped Behavior; Yawning | 1988 |
Synergistic effects of D1 and D2 dopamine agonists on turning behaviour in rats.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Benzazepines; Bromocriptine; Ergolines; Male; Motor Activity; Quinpirole; Rats; Rats, Inbred Strains; Receptors, Dopamine; Receptors, Dopamine D1; Receptors, Dopamine D2; Rotation | 1986 |
Bromocriptine-induced locomotor stimulation in mice is modulated by dopamine D-1 receptors.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Benzazepines; Bromocriptine; Dopamine; Drug Interactions; Male; Mice; Motor Activity; Receptors, Dopamine; Receptors, Dopamine D1; Sulpiride | 1987 |
Evidence that the stimulus properties of apomorphine are mediated by both D1 and D2 receptor activation.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Apomorphine; Benzazepines; Bromocriptine; Discrimination Learning; Dose-Response Relationship, Drug; Male; Rats; Rats, Inbred Strains; Receptors, Dopamine; Receptors, Dopamine D1; Receptors, Dopamine D2; Sex Factors | 1987 |
D-1 dopamine receptor stimulation potentiates neurophysiological effects of bromocriptine in rats with lesions of the nigrostriatal dopamine pathway.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Action Potentials; Animals; Benzazepines; Bromocriptine; Corpus Striatum; Drug Synergism; Hydroxydopamines; Male; Oxidopamine; Rats; Rats, Inbred Strains; Receptors, Dopamine; Receptors, Dopamine D1; Substantia Nigra | 1987 |
Dopaminergic agents selectively alter the post-translational processing of beta-endorphin in the intermediate pituitary of the rat.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Benzazepines; beta-Endorphin; Bromocriptine; Domperidone; Dopamine Antagonists; Ergolines; Haloperidol; Male; Pituitary Gland; Protein Processing, Post-Translational; Quinpirole; Rats; Rats, Inbred Strains; Receptors, Dopamine | 1987 |
Repeated stimulation of D-1 dopamine receptors increases the circling response to bromocriptine in rats with a 6-OHDA lesion.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; 3,4-Dihydroxyphenylacetic Acid; Animals; Appetite Depressants; Benzazepines; Bromocriptine; Corpus Striatum; Dopamine; Female; Homovanillic Acid; Hydroxydopamines; Locomotion; Oxidopamine; Rats; Rats, Inbred Strains; Receptors, Dopamine; Receptors, Dopamine D1; Receptors, Dopamine D2; Substantia Nigra | 1988 |
Dopaminergic modulation of hippocampal noradrenaline release. Evidence for alpha 2-antagonistic effects of some dopamine receptor agonists and antagonists.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Apomorphine; Benzazepines; Bromocriptine; Cocaine; Dopamine; Electric Stimulation; Ergolines; Hippocampus; In Vitro Techniques; Norepinephrine; Quinpirole; Rabbits; Receptors, Adrenergic, alpha; Receptors, Dopamine; Serotonin; Yohimbine | 1985 |
Bromocriptine induces marked locomotor stimulation in dopamine-depleted mice when D-1 dopamine receptors are stimulated with SKF38393.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Appetite Depressants; Benzazepines; Bromocriptine; Dopamine; Drug Interactions; Male; Mice; Motor Activity; Receptors, Dopamine; Reserpine | 1986 |
Dopaminergic inhibition of tyrosinase activity in hair follicular melanocytes of the mouse.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Aging; Animals; Benzazepines; Bromocriptine; Catechol Oxidase; Depression, Chemical; Dopamine; Ergolines; Female; Hair; Haloperidol; Male; Melanocytes; Mice; Mice, Inbred C3H; Monophenol Monooxygenase; Quinpirole; Skin; Spiperone; Sulpiride | 1986 |
Multifocal sites of action involved in dopaminergic-cholinergic neuronal interactions in yawning.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; alpha-Methyltyrosine; Animals; Apomorphine; Benzazepines; Bromocriptine; Male; Methyltyrosines; Physostigmine; Pilocarpine; Rats; Rats, Inbred Strains; Receptors, Cholinergic; Receptors, Dopamine; Yawning | 1988 |
D-1 and D-2 receptor blockade have additive cataleptic effects in mice, but receptor effects may interact in opposite ways.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Apomorphine; Benzazepines; Bromocriptine; Catalepsy; Male; Mice; Molindone; Motor Activity; Receptors, Dopamine | 1988 |
Characterization of dopamine receptors associated with aldosterone secretion in rat adrenal glomerulosa.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Adenylyl Cyclases; Adrenal Cortex; Aldosterone; Animals; Benzazepines; Bromocriptine; Dihydroergotoxine; Haloperidol; Lisuride; Male; Rats; Rats, Inbred Strains; Receptors, Dopamine; Stereoisomerism; Sulpiride | 1986 |
Induction of turning by direct intrastriatal injection of dopaminomimetic drugs in mice: pharmacological analysis of a simple screening model.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Apomorphine; Benzazepines; Bromocriptine; Dextroamphetamine; Dopamine; Female; Haloperidol; Mice; Nomifensine; Posture; Pyridazines; Stereotyped Behavior; Sulpiride; Time Factors | 1986 |
Coexistence of inhibitory dopamine D-1 and excitatory D-2 receptors on the same caudate nucleus neurons.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Action Potentials; Animals; Benzazepines; Bromocriptine; Cats; Caudate Nucleus; Domperidone; Dopamine; Haloperidol; Iontophoresis; Neurons; Receptors, Dopamine; Substantia Nigra | 1987 |
Characterization of dopamine autoreceptor and [3H]spiperone binding sites in vitro with classical and novel dopamine receptor agonists.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Adrenergic alpha-Agonists; Animals; Apomorphine; Benzazepines; Binding Sites; Bromocriptine; Butyrophenones; Cats; Caudate Nucleus; Dopamine; Electric Stimulation; Female; In Vitro Techniques; Male; Phentolamine; Receptors, Dopamine; Spiperone; Sulpiride; Tritium | 1983 |
Mouse locomotor activity: an in vivo test for dopamine autoreceptor activation.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Apomorphine; Benzazepines; Bromocriptine; Ergolines; Female; Methods; Mice; Motor Activity; Receptors, Dopamine; Sulpiride | 1984 |
Intravenous self-administration of dopamine receptor agonists by rhesus monkeys.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Apomorphine; Benzazepines; Bromocriptine; Cocaine; Dextroamphetamine; Dopamine; Female; Macaca mulatta; Male; Motor Activity; Piribedil; Receptors, Dopamine; Self Administration | 1984 |
A comparison of the responses to some dopamine-receptor agonists and antagonists in the isolated perfused rat kidney.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Apomorphine; Benzazepines; Bromocriptine; Dopamine; Dopamine Antagonists; Female; In Vitro Techniques; Kidney; Male; Metoclopramide; Rats; Receptors, Dopamine; Regional Blood Flow; Vasodilation | 1980 |
Differential effects of dopamine agonists in mature and immature rats.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Age Factors; Animals; Animals, Newborn; Apomorphine; Benzazepines; Bromocriptine; Dextroamphetamine; Dopamine; Female; Humans; Levodopa; Male; Motor Activity; Rats; Scopolamine; Stereotyped Behavior; Sympathomimetics | 1981 |
Comparison of the vasodilator action of dopamine and dopamine agonists in the renal and coronary beds of the dog.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Benzazepines; Bromocriptine; Coronary Circulation; Dogs; Dopamine; Ergotamine; Female; Heart Rate; Male; Metoclopramide; Propranolol; Renal Circulation; Vasodilator Agents | 1982 |
Time course of bromocriptine induced excitation in the rat: behavioural and biochemical studies.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; 3,4-Dihydroxyphenylacetic Acid; Animals; Behavior, Animal; Brain Chemistry; Bromocriptine; Dopamine; Hydroxyindoleacetic Acid; Kinetics; Male; Microdialysis; Motor Activity; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1 | 1995 |
Effects of SR 48692, a selective non-peptide neurotensin receptor antagonist, on two dopamine-dependent behavioural responses in mice and rats.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Apomorphine; Behavior, Animal; Bromocriptine; Dopamine; Dose-Response Relationship, Drug; Female; Male; Mice; Motor Activity; Penile Erection; Pyrazoles; Quinolines; Rats; Rats, Wistar; Receptors, Neurotensin; Stereotyped Behavior; Yawning | 1994 |
Involvement of D1 dopamine receptor mechanism in ischemia-induced impairment of CA1 presynaptic fiber spikes in rat hippocampal slices.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Action Potentials; Analysis of Variance; Animals; Benzazepines; Brain Ischemia; Bromocriptine; Dopamine Agonists; Ergolines; Hippocampus; In Vitro Techniques; Male; Nerve Fibers; Presynaptic Terminals; Quinpirole; Rats; Rats, Wistar; Receptors, Dopamine D1; Sulpiride | 1994 |
Dopamine receptor agonist reduces ethanol self-administration in the ethanol-preferring C57BL/6J inbred mouse.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Alcoholism; Animals; Blotting, Northern; Brain; Bromocriptine; Computer Simulation; Disease Models, Animal; Down-Regulation; Ethanol; Male; Mice; Mice, Inbred C57BL; Radioligand Assay; Receptors, Dopamine D1; Receptors, Dopamine D2; Regression Analysis; RNA, Messenger; Self Administration | 1994 |
On-off effects of dopamine receptor agonists in the hemi-parkinsonian rat.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Bromocriptine; Cocaine; Dopamine Agents; Dose-Response Relationship, Drug; Female; Injections, Intraperitoneal; Motor Activity; Oxidopamine; Parkinson Disease; Rats; Rats, Sprague-Dawley | 1993 |
Opposing roles for D-1 and D-2 dopamine receptors in the regulation of lower esophageal sphincter motility in the rat.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Benzazepines; Bromocriptine; Dihydroergotoxine; Dopamine; Dopamine Agents; Ergolines; Esophagogastric Junction; Fenoldopam; In Vitro Techniques; Male; Peristalsis; Phentolamine; Prazosin; Quinpirole; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; Receptors, Dopamine D2 | 1994 |
Comparative analysis of the behaviors evoked by bromocriptine and quinpirole (LY 171555) in adult cats.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Behavior, Animal; Bromocriptine; Cats; Dopamine Agents; Dose-Response Relationship, Drug; Drug Interactions; Ergolines; Female; Male; Quinpirole; Receptors, Dopamine D2 | 1994 |
Effects of D1 and D2 agonists on spontaneous motor activity in MPTP treated mice.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Behavior, Animal; Brain; Bromocriptine; Drug Combinations; Locomotion; Male; Mice; Mice, Inbred C57BL; Motor Activity; Receptors, Dopamine D1; Receptors, Dopamine D2 | 1994 |
Reward summation and the effects of dopamine D1 and D2 agonists and antagonists on fixed-interval responding for brain stimulation.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Amphetamine; Animals; Benzazepines; Brain; Bromocriptine; Conditioning, Operant; Dopamine D2 Receptor Antagonists; Drug Interactions; Electric Stimulation; Male; Rats; Rats, Wistar; Receptors, Dopamine D1; Receptors, Dopamine D2; Reinforcement Schedule; Reward; Self Stimulation; Spiperone | 1994 |
Depression of the monosynaptic reflex by apomorphine or bromocriptine is not mediated by D1/D2 receptors.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Apomorphine; Benzamides; Bromocriptine; Decerebrate State; Depression, Chemical; Dopamine Agents; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Ergolines; Male; Quinpirole; Rats; Rats, Wistar; Receptors, Dopamine D1; Receptors, Dopamine D2; Receptors, Dopamine D3; Reflex, Monosynaptic; Sulpiride; Synaptic Transmission | 1993 |
Adenosine receptor antagonists potentiate dopamine receptor agonist-induced rotational behavior in 6-hydroxydopamine-lesioned rats.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Bromocriptine; Male; Motor Activity; Oxidopamine; Purinergic P1 Receptor Antagonists; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; Receptors, Dopamine D2; Theobromine; Theophylline; Time Factors; Xanthines | 1993 |
Dopamine decreases striatal enkephalin turnover and proenkephalin messenger RNA abundance via D2 receptor activation in primary striatal cell cultures.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Blotting, Northern; Bromocriptine; Cells, Cultured; Corpus Striatum; Dopamine; Dopamine Antagonists; Enkephalin, Methionine; Enkephalins; Female; Potassium Chloride; Pregnancy; Protein Precursors; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D2; RNA, Messenger; Sulpiride | 1993 |
Dopaminergic inhibition of catecholamine secretion from chromaffin cells: evidence that inhibition is mediated by D4 and D5 dopamine receptors.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Adenylate Cyclase Toxin; Adenylyl Cyclases; Adrenal Medulla; Animals; Base Sequence; Benzazepines; Bromocriptine; Calcium; Catecholamines; Cattle; Cells, Cultured; Colforsin; Cyclic AMP; Depression, Chemical; Dimethylphenylpiperazinium Iodide; Dopamine; Dopamine Agonists; Molecular Sequence Data; Pertussis Toxin; Polymerase Chain Reaction; Potassium; Receptors, Dopamine; Receptors, Dopamine D1; Receptors, Dopamine D2; Receptors, Dopamine D4; Receptors, Dopamine D5; Second Messenger Systems; Veratridine; Virulence Factors, Bordetella | 1996 |
Levodopoa but not bromocriptine induces AP-1 and creb DNA-binding activity in the dopamine-depleted striatum of the rat.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Antiparkinson Agents; Base Sequence; Behavior, Animal; Bromocriptine; Corpus Striatum; Cyclic AMP Response Element-Binding Protein; Disease Models, Animal; Dopamine; Dopamine Agonists; Levodopa; Male; Molecular Sequence Data; Parkinson Disease, Secondary; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; Transcription Factor AP-1 | 1996 |
Differential inhibition of secretagogue-stimulated sodium uptake in adrenal chromaffin cells by activation of D4 and D5 dopamine receptors.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Adrenal Medulla; Analysis of Variance; Animals; Benzazepines; Biological Transport; Bromocriptine; Cattle; Cells, Cultured; Chromaffin Cells; Colforsin; Dimethylphenylpiperazinium Iodide; Kinetics; Receptors, Dopamine D1; Receptors, Dopamine D2; Receptors, Dopamine D4; Receptors, Dopamine D5; Sodium; Tetrodotoxin; Veratridine | 1996 |
Tremulous jaw movements induced by the acetylcholinesterase inhibitor tacrine: effects of antiparkinsonian drugs.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Antiparkinson Agents; Apomorphine; Bromocriptine; Cholinesterase Inhibitors; Cholinesterases; Dopamine Agonists; Drug Interactions; Male; Mastication; Rats; Rats, Sprague-Dawley; Tacrine | 1997 |
D1 dopamine receptor activity of anti-parkinsonian drugs.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Antiparkinson Agents; Apomorphine; Benzazepines; Benzothiazoles; Bromocriptine; Cells, Cultured; Cerebellum; Clozapine; Cyclic AMP; Dopamine; Dopamine Agonists; Dopamine Antagonists; Dose-Response Relationship, Drug; Pergolide; Pramipexole; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; Tetrahydronaphthalenes; Thiazoles | 1997 |
Regulation of tyrosine hydroxylase and aromatic L-amino acid decarboxylase by dopaminergic drugs.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Aromatic-L-Amino-Acid Decarboxylases; Benzazepines; Brain; Bromocriptine; Corpus Striatum; Dopamine Agonists; Dopamine Antagonists; Haloperidol; Male; Mesencephalon; Mice; Quinpirole; Receptors, Dopamine D1; Receptors, Dopamine D2; RNA, Messenger; Tetrahydronaphthalenes; Tyrosine 3-Monooxygenase | 1997 |
A sensitive assay for studying dopaminergic activity in cultures of rat pituitary cells.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Bromocriptine; Cell Count; Cells, Cultured; Cyproheptadine; Dopamine; Dopamine Agonists; Dopamine Antagonists; Drug Evaluation, Preclinical; Female; Haloperidol; Pituitary Gland; Prolactin; Rats; Rats, Wistar; Spiperone | 1997 |
Bromocriptine/SKF38393 treatment ameliorates obesity and associated metabolic dysfunctions in obese (ob/ob) mice.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Body Composition; Body Weight; Bromocriptine; Dopamine Agonists; Feeding Behavior; Male; Mice; Mice, Inbred C57BL; Mice, Obese; Obesity; Receptors, Dopamine D1 | 1997 |
Transient upregulation of mu opioid receptor mRNA levels in nucleus accumbens during chronic cocaine administration.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Analgesics, Opioid; Animals; Benzopyrans; Bromocriptine; Cocaine; Dopamine Agonists; Dopamine Uptake Inhibitors; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; Enkephalins; Gene Expression Regulation; Male; Nucleus Accumbens; Oxazines; Rats; Rats, Sprague-Dawley; Receptors, Opioid, mu; RNA, Messenger; Time Factors; Up-Regulation | 1998 |
Lysergic acid diethylamide (LSD) is a partial agonist of D2 dopaminergic receptors and it potentiates dopamine-mediated prolactin secretion in lactotrophs in vitro.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Bromocriptine; Cells, Cultured; Cyproheptadine; Dopamine; Dopamine Agonists; Dopamine Antagonists; Female; Lysergic Acid Diethylamide; Pituitary Gland; Prolactin; Rats; Rats, Wistar; Receptors, Dopamine D2 | 1998 |
Dopamine D2 receptor agonists protect against ischaemia-induced hippocampal neurodegeneration in global cerebral ischaemia.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Benzazepines; Brain Ischemia; Bromocriptine; Dopamine Agonists; Dopamine Antagonists; Gerbillinae; Haloperidol; Hippocampus; Lisuride; Neuroprotective Agents; Pergolide; Receptors, Dopamine D2 | 1998 |
Dopamine agonist treatment ameliorates hyperglycemia, hyperlipidemia, and the elevated basal insulin release from islets of ob/ob mice.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Blood Glucose; Bromocriptine; Colforsin; Cyclic AMP; Dopamine Agonists; Glucokinase; Glucose; Hexokinase; Hyperglycemia; Hyperlipidemias; In Vitro Techniques; Insulin; Insulin Secretion; Islets of Langerhans; Lipids; Mice; Mice, Inbred C57BL; Mice, Obese; Protein Kinase C; Tetradecanoylphorbol Acetate | 1998 |
Dopamine receptor subtypes modulate olfactory bulb gamma-aminobutyric acid type A receptors.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Bromocriptine; Cells, Cultured; Cholera Toxin; Cyclic AMP; Cyclic AMP-Dependent Protein Kinases; Dopamine; Embryo, Mammalian; gamma-Aminobutyric Acid; Neurons; Olfactory Bulb; Protein Kinase C; Rats; Receptors, Dopamine D1; Receptors, Dopamine D2; Receptors, GABA-A | 1999 |
Dopamine receptor coupling to adenylyl cyclase in rat olfactory pathway: a combined pharmacological-radioautographic approach.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Adenylyl Cyclases; Animals; Autoradiography; Benzazepines; Bromocriptine; Carbachol; Colforsin; Corpus Striatum; Dopamine; Dopamine Agonists; Dopamine Antagonists; Enzyme Activation; GTP-Binding Proteins; Guanosine Triphosphate; Male; Muscarinic Agonists; Nitriles; Odorants; Olfactory Bulb; Olfactory Mucosa; Olfactory Pathways; Quinpirole; Rats; Rats, Wistar; Receptors, Dopamine D1; Receptors, Dopamine D2; Salicylamides; Signal Transduction | 1999 |
Neurochemical evidence of dopamine release by lateral olivocochlear efferents and its presynaptic modulation in guinea-pig cochlea.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Axons; Bromocriptine; Cadmium Chloride; Calcium Signaling; Cochlea; Cochlear Nucleus; Dopamine; Dopamine Agonists; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Dopamine Uptake Inhibitors; Drug Interactions; Efferent Pathways; Feedback; Guinea Pigs; Male; Models, Neurological; Neuroprotective Agents; Nomifensine; Olivary Nucleus; Piribedil; Quinpirole; Receptors, Dopamine D1; Receptors, Dopamine D2; Receptors, Dopamine D3; Receptors, Presynaptic; Sulpiride; Tetrodotoxin | 1999 |
Biochemical mechanisms responsible for the attenuation of diabetic and obese conditions in ob/ob mice treated with dopaminergic agonists.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Adipose Tissue; Animals; Blood Glucose; Bromocriptine; Diabetes Mellitus; Dopamine Agonists; Drug Synergism; Eating; Energy Metabolism; Fatty Acids, Nonesterified; Female; Gluconeogenesis; Lipids; Lipolysis; Liver; Mice; Mice, Inbred C57BL; Mice, Obese; Obesity; Weight Loss | 1999 |
Bromocriptine/SKF38393 treatment ameliorates dyslipidemia in ob/ob mice.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Adipose Tissue; Animals; Bromocriptine; Dopamine Agonists; Drug Synergism; Drug Therapy, Combination; Female; Hyperlipidemias; Lipolysis; Lipoproteins; Mice; Mice, Obese; Receptors, Dopamine; Triglycerides | 1999 |
D1/D2 receptor synergism on CREB DNA-binding activities in the caudate-putamen of rat.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Bromocriptine; Cyclic AMP Response Element-Binding Protein; DNA; Dopamine Agonists; Electrophoresis; Male; Neostriatum; Protein Binding; Quinpirole; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; Receptors, Dopamine D2 | 1999 |
Increased responsiveness of ventromedial hypothalamic neurons to norepinephrine in obese versus lean mice: relation to the metabolic syndrome.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Bromocriptine; Dopamine Agonists; Electrophysiology; Female; Glutamic Acid; Hyperglycemia; Iontophoresis; Mice; Mice, Inbred C57BL; Mice, Obese; Neurons; Norepinephrine; Obesity; Receptors, Dopamine D1; Receptors, Dopamine D2; Syndrome; Ventromedial Hypothalamic Nucleus | 2000 |
Activity-dependent and use-dependent regulation of dopamine-receptor clustering.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Benzazepines; Binding Sites; Bromocriptine; Dopamine Agonists; Dopamine Antagonists; Microscopy, Confocal; Rats; Rats, Long-Evans; Receptor Aggregation; Receptors, Dopamine D1; Receptors, Dopamine D2; Spiperone | 2000 |
Activation of D1 and D2 dopamine receptors increases the activity of the somatostatin receptor-effector system in the rat frontoparietal cortex.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Benzazepines; Binding, Competitive; Bromocriptine; Cell Membrane; Colforsin; Dopamine Agonists; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Frontal Lobe; Male; Octreotide; Parietal Lobe; Raclopride; Rats; Rats, Wistar; Receptors, Dopamine D1; Receptors, Dopamine D2; Receptors, Somatostatin | 2000 |
Modulation of pituitary dopamine D1 or D2 receptors and secretion of follicle stimulating hormone and luteinizing hormone during the annual reproductive cycle of female rainbow trout.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Age Factors; Animals; Bromocriptine; Cells, Cultured; Dopamine Agonists; Female; Fertility Agents, Female; Follicle Stimulating Hormone; Follicular Phase; Gonadotropin-Releasing Hormone; In Vitro Techniques; Luteinizing Hormone; Oncorhynchus mykiss; Pituitary Gland; Receptors, Dopamine D1; Receptors, Dopamine D2; Sexual Maturation | 2000 |
Psychomotor-activating effects mediated by dopamine D(2) and D(3) receptors in the nucleus accumbens.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Behavior, Animal; Benzopyrans; Bromocriptine; Grooming; Indoles; Motor Activity; Naphthalenes; Nucleus Accumbens; Oxazines; Piperidines; Pyrrolidines; Rats; Rats, Wistar; Receptors, Dopamine D1; Receptors, Dopamine D2; Receptors, Dopamine D3 | 2000 |
Characterization of acute inhibition of Na/H exchanger NHE-3 by dopamine in opossum kidney cells.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Bromocriptine; Cells, Cultured; Cyclic AMP; Cyclic AMP-Dependent Protein Kinases; Dopamine; Dopamine Agonists; Dose-Response Relationship, Drug; Kidney; Opossums; Phosphorylation; Protein Kinase C; Receptors, Dopamine D1; Receptors, Dopamine D2; Sodium-Hydrogen Exchanger 3; Sodium-Hydrogen Exchangers; Time Factors | 2001 |
Dopamine modulates sodium currents in cochlear spiral ganglion neurons.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Action Potentials; Animals; Benzazepines; Bromocriptine; Dopamine; Dopamine Agonists; Dopamine Antagonists; In Vitro Techniques; Mice; Mice, Inbred C57BL; Neurons, Afferent; Patch-Clamp Techniques; Quinpirole; Receptors, Dopamine D1; Receptors, Dopamine D2; Sodium; Spiral Ganglion; Tetrodotoxin | 2001 |
Increased responsiveness to the hyperglycemic, hyperglucagonemic and hyperinsulinemic effects of circulating norepinephrine in ob/ob mice.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Adrenergic alpha-Agonists; Animals; Blood Glucose; Bromocriptine; Dopamine Agonists; Female; Glucagon; Glucose Clamp Technique; Hyperglycemia; Hyperinsulinism; Insulin; Insulin Secretion; Mice; Mice, Inbred C57BL; Mice, Obese; Norepinephrine; Random Allocation | 2001 |
Effects of pharmacological agents upon a transgenic model of Parkinson's disease in Drosophila melanogaster.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; alpha-Methyltyrosine; alpha-Synuclein; Animals; Animals, Genetically Modified; Antiparkinson Agents; Bromocriptine; Disease Models, Animal; Drosophila melanogaster; Genotype; Levodopa; Motor Activity; Nerve Tissue Proteins; Neurons; Parkinson Disease; Pergolide; Postural Balance; Synapses; Synucleins | 2002 |
Dopamine modulates synaptic transmission between rat olfactory bulb neurons in culture.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Bromocriptine; Calcium Channels; Cell Culture Techniques; Dopamine; Dopamine Agonists; Electrophysiology; Excitatory Postsynaptic Potentials; Immunohistochemistry; Interneurons; Neurons; Olfactory Bulb; Rats; Rats, Sprague-Dawley; Receptors, Dopamine; Receptors, Glutamate; Synaptic Transmission; Tyrosine 3-Monooxygenase | 2003 |
Bromocriptine and quinpirole, but not 7-OH-DPAT or SKF 38393, potentiate the inhibitory effect of L-NAME on ethanol-induced locomotor activity in mice.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Arginine; Bromocriptine; Dopamine Agonists; Dose-Response Relationship, Drug; Drug Synergism; Enzyme Inhibitors; Ethanol; Male; Mice; Motor Activity; NG-Nitroarginine Methyl Ester; Nitric Oxide; Quinpirole; Receptors, Dopamine D2; Receptors, Dopamine D3; Tetrahydronaphthalenes | 2003 |
Effects of dopamine agonists bromocriptine, pergolide, cabergoline, and SKF-38393 on GDNF, NGF, and BDNF synthesis in cultured mouse astrocytes.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Astrocytes; Blotting, Northern; Brain-Derived Neurotrophic Factor; Bromocriptine; Cabergoline; Dopamine Agonists; Dose-Response Relationship, Drug; Enzyme-Linked Immunosorbent Assay; Ergolines; Glial Cell Line-Derived Neurotrophic Factor; Mice; Mice, Inbred ICR; Nerve Growth Factor; Nerve Growth Factors; Pergolide; Receptors, Dopamine D1; Receptors, Dopamine D2; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Time Factors | 2003 |
Excitatory actions of dopamine via D1-like receptors in the rat lateral geniculate nucleus.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Action Potentials; Adrenergic alpha-Antagonists; Analysis of Variance; Anesthetics, Local; Animals; Animals, Newborn; Benzazepines; Bromocriptine; Carbazoles; Colforsin; Cyclic AMP; Dopamine; Dopamine Agonists; Dopamine Antagonists; Dose-Response Relationship, Drug; Drug Interactions; Electric Stimulation; Enzyme Inhibitors; Geniculate Bodies; In Vitro Techniques; Indoles; Neurons; Patch-Clamp Techniques; Prazosin; Pyrimidines; Pyrroles; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; Tetrodotoxin; Thionucleotides | 2005 |
Differential involvement of D1 and D2 dopamine receptors in L-DOPA-induced angiogenic activity in a rat model of Parkinson's disease.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Aminoacetonitrile; Animals; Antiparkinson Agents; Basal Ganglia; Benzazepines; Bromocriptine; Disease Models, Animal; Dopamine Agents; Dopamine D2 Receptor Antagonists; Extracellular Signal-Regulated MAP Kinases; Female; Levodopa; Neovascularization, Pathologic; Oxidopamine; Parkinsonian Disorders; Protease Inhibitors; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; Receptors, Dopamine D2; Salicylamides | 2009 |
The effect of dopamine agonists: the expression of GDNF, NGF, and BDNF in cultured mouse astrocytes.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Apomorphine; Astrocytes; Brain-Derived Neurotrophic Factor; Bromocriptine; Cells, Cultured; Dopamine Agonists; Dose-Response Relationship, Drug; Enzyme-Linked Immunosorbent Assay; Glial Cell Line-Derived Neurotrophic Factor; Indoles; Mice; Mice, Inbred ICR; Nerve Growth Factor; Receptors, Dopamine D1; Receptors, Dopamine D2; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Time Factors | 2010 |
Working memory span capacity improved by a D2 but not D1 receptor family agonist.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Bromocriptine; Dopamine Agonists; Male; Maze Learning; Memory, Long-Term; Memory, Short-Term; Mice; Mice, Inbred C57BL; Receptors, Dopamine D1; Receptors, Dopamine D2 | 2011 |
Differential effects of dopamine receptor subtype-specific agonists with respect to operant behavior maintained on a differential reinforcement of low-rate responding (DRL) schedule.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Benzamides; Bromocriptine; Conditioning, Operant; Dopamine Agonists; Dose-Response Relationship, Drug; Male; Piperazines; Quinpirole; Rats; Reinforcement Schedule; Time Factors | 2015 |